_id
691093c5ccc777a4e85d5a59
Ticker
ECOR
Name
Electrocore LLC
Exchange
NASDAQ
Address
200 Forge Way, Rockaway, NJ, United States, 07866
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.electrocore.com
Description
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Last Close
4.82
Volume
11287
Current Price
4.75
Change
-1.4522821576763543
Last Updated
2025-11-29T12:32:38.795Z
Image
-
Ipo Date
2018-06-22T00:00:00.000Z
Market Cap
40379312
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.986
Sentiment Sources
2
Rating
4.6
Target Price
21.136
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8689000
Cost Of Revenue
1219000
Gross Profit
7470000
Operating Expenses
10354000
Operating Income
-2884000
Interest Expense
208000
Pretax Income
-3405000
Net Income
-3405000
Eps
-0.40319715808170514
Dividends Per Share
-
Shares Outstanding
7995903
Income Tax Expense
-
EBITDA
-3044000
Operating Margin
-33.19139141443204
Total Other Income Expense Net
-521000
Cash
8106999
Short Term Investments
5094000
Receivables
1478000
Inventories
1210000
Total Current Assets
17347000
Property Plant Equipment
3822000
Total Assets
21412000
Payables
3069000
Short Term Debt
465000
Long Term Debt
6526000
Total Liabilities
22485000
Equity
-1073000
Depreciation
153000
Change In Working Capital
1052000
Cash From Operations
-1669000
Capital Expenditures
4000
Cash From Investing
-1326000
Cash From Financing
7484000
Net Change In Cash
4483999
PE
-
PB
-37.38466915191053
ROE
317.3345759552656
ROA
-15.902297776947504
FCF
-1673000
Fcf Percent
-0.1925422948555645
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8689000
Quarters > 0 > income Statement > cost Of Revenue
1219000
Quarters > 0 > income Statement > gross Profit
7470000
Quarters > 0 > income Statement > operating Expenses
10354000
Quarters > 0 > income Statement > operating Income
-2884000
Quarters > 0 > income Statement > interest Expense
208000
Quarters > 0 > income Statement > pretax Income
-3405000
Quarters > 0 > income Statement > net Income
-3405000
Quarters > 0 > income Statement > eps
-0.40319715808170514
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8445000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3044000
Quarters > 0 > income Statement > operating Margin
-33.19139141443204
Quarters > 0 > income Statement > total Other Income Expense Net
-521000
Quarters > 0 > balance Sheet > cash
8106999
Quarters > 0 > balance Sheet > short Term Investments
5094000
Quarters > 0 > balance Sheet > receivables
1478000
Quarters > 0 > balance Sheet > inventories
1210000
Quarters > 0 > balance Sheet > total Current Assets
17347000
Quarters > 0 > balance Sheet > property Plant Equipment
3822000
Quarters > 0 > balance Sheet > total Assets
21412000
Quarters > 0 > balance Sheet > payables
3069000
Quarters > 0 > balance Sheet > short Term Debt
465000
Quarters > 0 > balance Sheet > long Term Debt
6526000
Quarters > 0 > balance Sheet > total Liabilities
22485000
Quarters > 0 > balance Sheet > equity
-1073000
Quarters > 0 > cash Flow > net Income
-3405000
Quarters > 0 > cash Flow > depreciation
153000
Quarters > 0 > cash Flow > change In Working Capital
1052000
Quarters > 0 > cash Flow > cash From Operations
-1669000
Quarters > 0 > cash Flow > capital Expenditures
4000
Quarters > 0 > cash Flow > cash From Investing
-1326000
Quarters > 0 > cash Flow > cash From Financing
7484000
Quarters > 0 > cash Flow > net Change In Cash
4483999
Quarters > 0 > ratios > PE
-0.40319715808170514
Quarters > 0 > ratios > PB
-37.38466915191053
Quarters > 0 > ratios > ROE
317.3345759552656
Quarters > 0 > ratios > ROA
-15.902297776947504
Quarters > 0 > ratios > FCF
-1673000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.1925422948555645
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
7381000
Quarters > 1 > income Statement > cost Of Revenue
939000
Quarters > 1 > income Statement > gross Profit
6442000
Quarters > 1 > income Statement > operating Expenses
9948000
Quarters > 1 > income Statement > operating Income
-3506000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3671000
Quarters > 1 > income Statement > net Income
-3671000
Quarters > 1 > income Statement > eps
-0.44143819143819146
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8316000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3512000
Quarters > 1 > income Statement > operating Margin
-47.50033870749221
Quarters > 1 > income Statement > total Other Income Expense Net
-165000
Quarters > 1 > balance Sheet > cash
3373000
Quarters > 1 > balance Sheet > short Term Investments
3772000
Quarters > 1 > balance Sheet > receivables
813000
Quarters > 1 > balance Sheet > inventories
1427000
Quarters > 1 > balance Sheet > total Current Assets
10557000
Quarters > 1 > balance Sheet > property Plant Equipment
3860000
Quarters > 1 > balance Sheet > total Assets
14559000
Quarters > 1 > balance Sheet > payables
2567000
Quarters > 1 > balance Sheet > short Term Debt
405000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13446000
Quarters > 1 > balance Sheet > equity
1113000
Quarters > 1 > cash Flow > net Income
-3671000
Quarters > 1 > cash Flow > depreciation
159000
Quarters > 1 > cash Flow > change In Working Capital
1714000
Quarters > 1 > cash Flow > cash From Operations
-623000
Quarters > 1 > cash Flow > capital Expenditures
25000
Quarters > 1 > cash Flow > cash From Investing
185000
Quarters > 1 > cash Flow > cash From Financing
3000
Quarters > 1 > cash Flow > net Change In Cash
-404000
Quarters > 1 > ratios > PE
-0.44143819143819146
Quarters > 1 > ratios > PB
35.490566037735846
Quarters > 1 > ratios > ROE
-329.8292902066487
Quarters > 1 > ratios > ROA
-25.21464386290267
Quarters > 1 > ratios > FCF
-648000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.08779298198076141
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
6719000
Quarters > 2 > income Statement > cost Of Revenue
1013000
Quarters > 2 > income Statement > gross Profit
5706000
Quarters > 2 > income Statement > operating Expenses
9528000
Quarters > 2 > income Statement > operating Income
-3822000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3903000
Quarters > 2 > income Statement > net Income
-3855000
Quarters > 2 > income Statement > eps
-0.4650741947158885
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
8289000
Quarters > 2 > income Statement > income Tax Expense
-48000
Quarters > 2 > income Statement > EBITDA
-3628000
Quarters > 2 > income Statement > operating Margin
-56.883464801309714
Quarters > 2 > income Statement > total Other Income Expense Net
-81000
Quarters > 2 > balance Sheet > cash
3777000
Quarters > 2 > balance Sheet > short Term Investments
3982000
Quarters > 2 > balance Sheet > receivables
1459000
Quarters > 2 > balance Sheet > inventories
1733000
Quarters > 2 > balance Sheet > total Current Assets
11972000
Quarters > 2 > balance Sheet > property Plant Equipment
3883000
Quarters > 2 > balance Sheet > total Assets
16041000
Quarters > 2 > balance Sheet > payables
1764000
Quarters > 2 > balance Sheet > short Term Debt
364000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11676000
Quarters > 2 > balance Sheet > equity
4365000
Quarters > 2 > cash Flow > net Income
-3855000
Quarters > 2 > cash Flow > depreciation
194000
Quarters > 2 > cash Flow > change In Working Capital
-1355000
Quarters > 2 > cash Flow > cash From Operations
-4355000
Quarters > 2 > cash Flow > capital Expenditures
37000
Quarters > 2 > cash Flow > cash From Investing
4500000
Quarters > 2 > cash Flow > cash From Financing
180000
Quarters > 2 > cash Flow > net Change In Cash
327000
Quarters > 2 > ratios > PE
-0.4650741947158885
Quarters > 2 > ratios > PB
9.020103092783504
Quarters > 2 > ratios > ROE
-88.31615120274914
Quarters > 2 > ratios > ROA
-24.032167570600336
Quarters > 2 > ratios > FCF
-4392000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.6536687006995089
Quarters > 2 > health Score
12
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7046000
Quarters > 3 > income Statement > cost Of Revenue
994000
Quarters > 3 > income Statement > gross Profit
6052000
Quarters > 3 > income Statement > operating Expenses
9123000
Quarters > 3 > income Statement > operating Income
-3071000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3199000
Quarters > 3 > income Statement > net Income
-3228000
Quarters > 3 > income Statement > eps
-0.4313777896565549
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7483000
Quarters > 3 > income Statement > income Tax Expense
29000
Quarters > 3 > income Statement > EBITDA
-2491000
Quarters > 3 > income Statement > operating Margin
-43.58501277320465
Quarters > 3 > income Statement > total Other Income Expense Net
-128000
Quarters > 3 > balance Sheet > cash
3450000
Quarters > 3 > balance Sheet > short Term Investments
8519000
Quarters > 3 > balance Sheet > receivables
1367000
Quarters > 3 > balance Sheet > inventories
1676000
Quarters > 3 > balance Sheet > total Current Assets
16300000
Quarters > 3 > balance Sheet > property Plant Equipment
3897000
Quarters > 3 > balance Sheet > total Assets
20471000
Quarters > 3 > balance Sheet > payables
1827000
Quarters > 3 > balance Sheet > short Term Debt
361000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
12927000
Quarters > 3 > balance Sheet > equity
7544000
Quarters > 3 > cash Flow > net Income
-3228000
Quarters > 3 > cash Flow > depreciation
580000
Quarters > 3 > cash Flow > change In Working Capital
828000
Quarters > 3 > cash Flow > cash From Operations
-1255000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-501000
Quarters > 3 > cash Flow > cash From Financing
371000
Quarters > 3 > cash Flow > net Change In Cash
-1479000
Quarters > 3 > ratios > PE
-0.4313777896565549
Quarters > 3 > ratios > PB
4.711591993637327
Quarters > 3 > ratios > ROE
-42.78897136797455
Quarters > 3 > ratios > ROA
-15.76864833178643
Quarters > 3 > ratios > FCF
-1255000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.17811524269088844
Quarters > 3 > health Score
20
Valuation > metrics > PE
-0.40319715808170514
Valuation > metrics > PB
-37.38466915191053
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
317.3345759552656
Profitability > metrics > ROA
-19.628754251455582
Profitability > metrics > Net Margin
-0.3918747842099206
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-13.865384615384615
Risk > final Score
-25
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.908602150537634
Liquidity > metrics > Quick Ratio
4.566213921901528
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
32.884080063626726
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-82
Prev Risks > 1
-38
Prev Risks > 2
13
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:24:49.534Z
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABull Bear: Will CDRO stock outperform value stocks - July 2025 Volume & Weekly High Return Stock Forecasts moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$21.136
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 20.03% of the total shares of Electrocore LLC
1.
Awm Investment Company Inc(3.5594%)
since
2025/06/30
2.
Vanguard Group Inc(3.0637%)
since
2025/06/30
3.
Renaissance Technologies Corp(2.3826%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(1.8554%)
since
2025/07/31
5.
International Assets Investment Management, LLC(1.0156%)
since
2025/06/30
6.
Geode Capital Management, LLC(0.8775%)
since
2025/06/30
7.
Goss Wealth Management LLC(0.817%)
since
2025/06/30
8.
Vanguard Institutional Extnd Mkt Idx Tr(0.8168%)
since
2025/07/31
9.
Sontag Advisory LLC(0.6263%)
since
2025/06/30
10.
JAFFETILCHIN INVESTMENT PARTNERS, LLC(0.551%)
since
2025/06/30
11.
HighTower Advisors, LLC(0.466%)
since
2025/06/30
12.
Fidelity Extended Market Index(0.4018%)
since
2025/07/31
13.
BlackRock Inc(0.3589%)
since
2025/06/30
14.
State Street Corp(0.3497%)
since
2025/06/30
15.
Two Sigma Investments LLC(0.2686%)
since
2025/06/30
16.
Morgan Stanley - Brokerage Accounts(0.2436%)
since
2025/06/30
17.
Perritt Capital Management Inc.(0.1978%)
since
2025/06/30
18.
Perritt MicroCap Opportunities Investor(0.1978%)
since
2025/06/30
19.
Jump Financial LLC(0.1774%)
since
2025/06/30
20.
iShares Micro-Cap ETF(0.174%)
since
2025/08/31
21.
Northern Trust Corp(0.1466%)
since
2025/06/30
22.
Fidelity Nasdaq Composite Index(0.1429%)
since
2025/07/31
23.
Extended Equity Market Fund K(0.1344%)
since
2025/06/30
24.
TOBIAS FINANCIAL ADVISORS, INC.(0.1319%)
since
2025/06/30
25.
UBS Group AG(0.1184%)
since
2025/06/30
26.
Fidelity Total Market Index(0.1159%)
since
2025/07/31
27.
Bridgeway Ultra-Small Company(0.1118%)
since
2025/06/30
28.
Fidelity Series Total Market Index(0.1001%)
since
2025/07/31
29.
Spartan Extended Market Index Pool F(0.0993%)
since
2025/07/31
30.
Northern Trust Extended Eq Market Idx(0.0842%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - L(0.0842%)
since
2025/06/30
32.
NT Ext Equity Mkt Idx Fd - NL(0.0604%)
since
2025/06/30
33.
Bfsg, LLC(0.0509%)
since
2025/06/30
34.
Spartan Total Market Index Pool G(0.0501%)
since
2025/07/31
35.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0488%)
since
2024/12/31
36.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0469%)
since
2025/06/30
37.
Vanguard Balanced Index Inv(0.0418%)
since
2025/07/31
38.
State St US Extended Mkt Indx NL Cl C(0.0296%)
since
2025/08/31
39.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0238%)
since
2025/06/30
40.
Kozak & Associates, Inc.(0.0088%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.